These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1773484)

  • 1. Proinsulin: biosynthesis, conversion, assay methods and clinical studies.
    Csorba TR
    Clin Biochem; 1991 Dec; 24(6):447-54. PubMed ID: 1773484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of plasma proinsulins, insulin and C-peptide].
    Chevenne D; Letailleur A; Trivin F; Porquet D
    Ann Biol Clin (Paris); 1995; 53(1-2):3-9. PubMed ID: 7574089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
    Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.
    Ostrega D; Polonsky K; Nagi D; Yudkin J; Cox LJ; Clark PM; Hales CN
    Diabetes; 1995 Apr; 44(4):437-40. PubMed ID: 7698513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing.
    Rhodes CJ; Lincoln B; Shoelson SE
    J Biol Chem; 1992 Nov; 267(32):22719-27. PubMed ID: 1429623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinsulin and C-peptide: a review.
    Kitabchi AE
    Metabolism; 1977 May; 26(5):547-87. PubMed ID: 403392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of proinsulin by transfected hepatoma (FAO) cells.
    Vollenweider F; Irminger JC; Gross DJ; Villa-Komaroff L; Halban PA
    J Biol Chem; 1992 Jul; 267(21):14629-36. PubMed ID: 1634510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin processing in the regulated and the constitutive secretory pathway.
    Halban PA
    Diabetologia; 1994 Sep; 37 Suppl 2():S65-72. PubMed ID: 7821742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of a highly conserved tetrapeptide sequence of the proinsulin connecting peptide (C-peptide) inhibits proinsulin to insulin conversion by transfected pituitary corticotroph (AtT20) cells.
    Gross DJ; Villa-Komaroff L; Kahn CR; Weir GC; Halban PA
    J Biol Chem; 1989 Dec; 264(36):21486-90. PubMed ID: 2689438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on proinsulin and problucagon biosynthesis and conversion at the subcellular level. II. Distribution of radioactive peptide hormones and hormone precursors in subcellular fractions after pulse and pulse-chase incubation of islet tissue.
    Noe BD; Baste CA; Bauer GE
    J Cell Biol; 1977 Aug; 74(2):589-604. PubMed ID: 328518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proinsulin C-peptide--a multirole model.
    Steiner DF
    Exp Diabesity Res; 2004; 5(1):7-14. PubMed ID: 15198367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases.
    Hutton JC
    Diabetologia; 1994 Sep; 37 Suppl 2():S48-56. PubMed ID: 7821740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.
    Sobey WJ; Beer SF; Carrington CA; Clark PM; Frank BH; Gray IP; Luzio SD; Owens DR; Schneider AE; Siddle K
    Biochem J; 1989 Jun; 260(2):535-41. PubMed ID: 2669734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway.
    Rhodes CJ; Halban PA
    J Cell Biol; 1987 Jul; 105(1):145-53. PubMed ID: 3301864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin endoproteolysis confers enhanced targeting of processed insulin to the regulated secretory pathway.
    Kuliawat R; Prabakaran D; Arvan P
    Mol Biol Cell; 2000 Jun; 11(6):1959-72. PubMed ID: 10848622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.
    Sizonenko SV; Halban PA
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):621-5. PubMed ID: 1898351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability to process and store proinsulin in transdifferentiated pancreatic acinar cells lacking the regulated secretory pathway.
    Aldibbiat A; Marriott CE; Scougall KT; Campbell SC; Huang GC; Macfarlane WM; Shaw JA
    J Endocrinol; 2008 Jan; 196(1):33-43. PubMed ID: 18180315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.